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Abstract
Dengue is one of the most important vector-borne diseases, resulting in an estimated hun-
dreds of millions of infections annually throughout the tropics. Control of dengue is heavily
dependent upon control of its primary mosquito vector, Aedes aegypti. Innovative interven-
tions that are effective at targeting the adult stage of the mosquito are needed to increase
the options for effective control. The use of insecticide-treated curtains (ITCs) has previously
been shown to significantly reduce the abundance of Ae. aegypti in and around homes, but
the impact of ITCs on dengue virus (DENV) transmission has not been rigorously quantified.
A parallel arm cluster-randomized controlled trial was conducted in Iquitos, Peru to quantify
the impact of ITCs on DENV seroconversion as measured through plaque-reduction neu-
tralization tests. Seroconversion data showed that individuals living in the clusters that
received ITCs were at greater risk to seroconverting to DENV, with an average seroconver-
sion rate of 50.6 per 100 person-years (PY) (CI: 29.9–71.9), while those in the control arm
had an average seroconversion rate of 37.4 per 100 PY (CI: 15.2–51.7). ITCs lost their
insecticidal efficacy within 6 months of deployment, necessitating re-treatment with insecti-
cide. Entomological indicators did not show statistically significant differences between ITC
and non-ITC clusters. It’s unclear how the lack of protective efficacy reported here is attribut-
able to simple failure of the intervention to protect against Ae. aegypti bites, or the presence
of a faulty intervention during much of the follow-up period. The higher risk of dengue sero-
conversion that was detected in the ITC clusters may have arisen due to a false sense of
security that inadvertently led to less routine protective behaviors on the part of households
that received the ITCs. Our study provides important lessons learned for conducting
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Author summary
Dengue is one of the most important mosquito-borne diseases effecting humans, resulting
in an estimated hundreds of millions of infections annually throughout the tropics. To
control dengue, most public health programs use a variety of methods to kill the primary
mosquito vector, Aedes aegypti. Water holding containers that harbor larvae (and other
immature stages) are treated or eliminated. During emergencies, large insecticide spray
campaigns are deployed to kill infected adult mosquitoes. Innovative interventions that
are effective at targeting adult mosquitoes in sustainable ways are needed to increase the
options for control of dengue and other Aedes borne virus diseases. The use of insecticide-
treated curtains (ITCs) has previously been shown to significantly reduce Ae. aegypti
numbers in and around homes, but the impact of ITCs on dengue virus (DENV) trans-
mission has not previously been quantified. Using a rigorous study design in which 10
clusters (~90 houses per cluster) were provided multiple ITCs to place in their homes was
compared to 10 clusters of homes without ITCs. Assignment of which clusters received
ITCs was randomized. Blood samples were obtained at 9-month intervals from residents
living in all the clusters, so that people with serological evidence of a DENV infection
could be identified by comparing paired samples. Seroconversion data showed that indi-
viduals living in the clusters that received ITCs were at greater risk to DENV seroconvert-
ing, with an average seroconversion rate of 50.6 per 100 person-years (PY) (CI: 29.9–
71.9). Conversely, those in the control arm had an average seroconversion rate of 37.4 per
100 PY (CI: 15.2–51.7). ITCs lost their insecticidal efficacy within 6 months of deploy-
ment, necessitating re-treatment with insecticide. Ae. aegypti populations did not show
statistically significant differences between ITC and non-ITC clusters. The reason for
higher transmission in the ITC treated clusters could be attributable to failure of the cur-
tains (loss of efficacy) and/or that the curtains were not sufficiently effective at protecting
against mosquito bites. The higher risk of DENV seroconversion in ITC clusters may be
due to a false sense of security that inadvertently led to less routine protective behaviors
on the part of households that received the ITC.
Introduction
Dengue is a major public health problem, with an estimated 390 million dengue virus (DENV)
infections occurring annually worldwide [1]. Control of the peridomestic DENV mosquito
vector, Aedes aegypti (and to a lesser extent, Aedes albopictus), is currently the primary preven-
tive measure. Existing vector control methods largely target immature mosquito stages, requir-
ing continuous effort by communities [2], and are often challenging to sustain [3]. Because
adult mosquitoes are responsible for virus transmission, targeting adults, rather than the
aquatic stages, should have the most direct impact on virus transmission. The most common
interventions targeting adult Ae. aegypti employ ultra-low volume (ULV) insecticide spray
applications. ULV spraying does not offer any residual insecticidal effect, and studies indicate
that ULV spraying is ineffective unless repeated frequently at closely timed intervals [4].
Hence, it is most practical when employed for outbreak response rather than for routine
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dengue control [4–6]. Novel interventions utilizing residual insecticides that target adult Ae.
aegypti are needed to increase the options for effective dengue vector control programs.
Insecticide-treated materials (ITMs) deployed as bednets are highly effective in preventing
transmission of malaria [7] and other nocturnally transmitted vector-borne diseases including
Chagas disease [8], leishmaniasis [9], and lymphatic filariasis [10]. Control of dengue diurnal
vectors using ITMs has similarly been demonstrated, mainly as insecticide treated curtains
(ITCs) [11–16]. The residual formulations of insecticides used on ITCs allow for a potentially
long-lasting effect, and ITCs are ‘user-friendly’, requiring little additional work or behavioral
change by householders. They are also well accepted by communities [17], because their per-
ceived efficacy is reinforced by the reduction in other biting insects, cockroaches, houseflies
and other insect pests [11].
Despite a body of evidence reporting the entomological impact of ITCs on Ae. aegypti,
little is known about their epidemiological impact on dengue or other arboviral infections.
Although preliminary evidence suggested that ITCs could impact Ae. aegypti populations at
a level that could reduce DENV transmission [11, 16], the epidemiological effect has not
been rigorously evaluated. To address this gap, we carried out a cluster-randomized con-
trolled trial of ITCs in Iquitos, Peru.
DENV transmission re-emerged in Iquitos in 1990 after a 30-year absence, and successive
epidemics occurred with subsequent DENV serotype invasions periodically since then [18–
25]. Routine Ae. aegypti control in Iquitos consisted of larviciding and health education activi-
ties utilizing billboards, radio, and TV messages focusing on preventive vector control activities
(removal and management of potential and actual larval habitats) and recognition of dengue
symptoms, especially early warning signs of severe disease. In response to increases in reported
dengue cases or elevated Ae. aegypti indices, emergency measures, including ULV spraying
and city-wide cleanup campaigns (collection of water-holding containers), were employed [19,
21, 22, 26–30]. The extensive longitudinal data on the dynamics of serotype-specific DENV
transmission over many years in Iquitos was used to design a vector control trial with epidemi-
ological endpoints [26, 27, 31]. Herein, we report the outcomes of an Iquitos ITC trial.
Materials and methods
Ethical approval
This study received approval from the Institutional Review Boards (IRBs) at the Liverpool
School of Tropical Medicine, the Tulane School of Public Health and Tropical Medicine, the
London School of Hygiene and Tropical Medicine, the University of California at Davis, and
the U.S. Naval Medical Research Center Detachment (now the U.S. Naval Medical Research
Unit-6) in Peru (S1 Protocol). The latter had interinstitutional IRB agreements with the Tulane
School of Public Health and Tropical Medicine and the University of California at Davis. The
Regional Health Authority (DIRESA), the local branch of the Peruvian Ministry of Health, also
provided approval. The trial was registered with the International Standard Randomized Con-
trolled Trial Register: ISRCTN08474420. Verbal consent was obtained for ITC deployment and
entomological monitoring activities, as approved by all IRBs. Written consent was obtained for
all blood draws from study participants (� 18 years of age) or a parent or guardian (if the par-
ticipant was between 3–17 years of age). Assent was obtained for all participants < 18 years of
age, with written documentation of assent for all children> 7 years of age.
Study site and design
Our parallel arm cluster-randomized controlled trial began during October 2009 in the district
of San Juan in Iquitos, which is located in the Amazon region of north-eastern Peru (73.2˚W
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longitude, 3.7˚S latitude, 120 m above sea level). The primary outcome measure was reduction
of DENV seroconversion, as measured by detection of dengue-specific plaque reduction neu-
tralizing antibodies in human blood taken from householders within the study area (Fig 1 and
S1 Checklist). Twenty clusters (consisting of 1–3 city blocks each containing a minimum of 70
households) were selected for the study (Fig 2). In late September 2009, prior to commence-
ment of field activities, treatment was randomized so that 10 clusters received ITCs and 10
Fig 1. CONSORT flowchart describing the recruitment and retention of participants and allocation to each study arm.
https://doi.org/10.1371/journal.pntd.0008097.g001
PLOS NEGLECTED TROPICAL DISEASES Insecticide treated curtains for dengue in Iquitos, Peru
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008097 April 10, 2020 4 / 17
Fig 2. Map of the study area showing the location of the twenty clusters, randomized to either receive ITCs or act as an untreated control (no
ITCs). This figure was created using QGIS software using shapefiles created as described previously [32, 33].
https://doi.org/10.1371/journal.pntd.0008097.g002
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clusters did not receive ITCs (control clusters). Clusters were allocated to the intervention or
control arm by simple randomization using a lottery: each cluster was represented by a piece
of paper which was drawn in turn from a bag by study personnel. ITCs were allocated at the
start of the trial, which obviated the need for allocation concealment. Clusters were geographi-
cally contiguous in the same region of the city.
The sample size calculation was based on data from 2 previous studies [29, 34] using DENV
PRNT status at 9-month intervals in residents of Iquitos. Hayes & Bennett’s [35] sample size
calculation method for binary data was used with the following parameters, which were chosen
to lie within the range of values found in the previous studies: average of 120 people at risk per
clusters, between-cluster coefficient of variation of 0.30, significance level 5% (two-sided), and
seroconversion rate in control and intervention clusters of 0.25 and 0.1375/year respectively
(55% efficacy). Using these parameters, 10 clusters per arm were needed for 90% power. This
was estimated to provide 4,000 blood samples at baseline (2,000 per arm; more than the 1350
required to detect a difference) and an estimated 2,000 at each subsequent sample period,
assuming that >50% of the population remained susceptible to>1 serotype. All individuals
above the age of 3 years living in the study area who consented to provide baseline and follow-
up blood samples were enrolled in a longitudinal cohort. Blood samples were collected from
the study population at baseline and at 9-months after the ITCs were distributed. No clusters
were lost to follow-up (Fig 2).
Intervention. During November 2009, ITCs were distributed in the clusters randomly
allocated to receive ITCs. Control clusters did not receive ITCs. The trial, therefore, was not
blinded. Residents could request as many curtains as they wanted and directed staff to where
they should be hung. Most were hung in windows, doors, walls, and used as room dividers.
Participants could choose among pink, light blue, and dark blue curtain colors. Surveys of cur-
tain coverage were carried out in December 2010 and June 2011, and additional curtains were
distributed subsequently according to need, with a total of 4,227 ITCs distributed over the
course of the trial. The ITCs distributed at the beginning of the trial were made from Permanet
2.0 (Vestergaard Frandsen, Lausanne, Switzerland; deltamethrin-treated).
Routine monitoring of insecticidal efficacy using WHO cone bioassays [36] was imple-
mented. At baseline, 12 new curtains were tested and showed 100% mortality using the local
susceptible Bellavista-Nanay Ae. aegypti strain. After the ITCs had been hanging for 6 months
(May 2010), a representative sample of 18 curtains was collected from randomly selected
houses, according to a matrix of characteristics (6 of each colour, exposed to either sun or
shade and washed 0, 1 or>1 times). Results were highly variable and ranged from 34%-100%
mortality, with 8 of the curtains falling below the 80% mortality threshold, with no discernible
pattern attributable to curtain color, sun exposure, or washing frequency. After hanging for 8
months (July 2010), a further 18 ITCs were selected for testing using the same methodology.
Results showed further declines in bioefficacy, with 13 of the curtains falling below the 80%
mortality threshold (range: 14%-100%). After hanging for 11 months (October 2010), the
same process was repeated and all except for 1 curtain fell below the 80% mortality threshold
(range: 32%-98%). Therefore, to ensure an effective intervention was present in the treated
households for the remaining period of the study, curtains were re-treated with deltamethrin
in the form of KO Tab 123 (Bayer) during November 2010, with a total of 3886 curtains
(91.9%) re-treated. Further cone bioassays to assess ITC efficacy were conducted 1 month fol-
lowing re-treatment (January 2011) and 9-months following re-treatment (August 2011) using
the susceptible New Orleans Ae. aegypti strain.
DENV transmission. After receiving informed consent, blood samples were collected by
either finger stick or venipuncture, the former usually being more acceptable, at baseline and
at 9-months post-ITC distribution. Samples were analyzed for DENV neutralizing antibodies
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using a plaque-reduction neutralization test (PRNT) with a 70% reduction for the cut-off
(PRNT70). PRNT70 were performed as described by Morrison et al. [29] for each DENV sero-
type (1–4) at the following serum dilutions: 1:40, 1:80, 1:160, and 1:640. Probit analysis was
carried out to determine the estimated endpoint titers for each serotype. A serum sample was
considered positive for DENV if a dilution neutralized 70% of the test virus at the following
cut-off titers: 1:60 for DENV1 and DENV3, 1:80 for DENV2, and 1:40 for DENV4. A serocon-
version was scored when the percent increase in reduction between a negative sample and a
subsequent sample was greater than 2-fold. During the study period Iquitos experienced a
DENV4 outbreak. Consequently, most new infections were presumed to be DENV4. The
primary outcome of our trial was seroconversion over the course of the follow-up period.
Entomological surveys. To examine the impact of the ITCs on adult and immature Ae.
aegypti abundance longitudinal entomological surveillance was implemented at the beginning
of the study, with a baseline entomological survey during October 2009. Larval and pupal sur-
veys and adult mosquito collections using battery-operated aspirators [37] were conducted in
all houses in treatment and control clusters. The first follow-up entomological survey occurred
during January 2010 and subsequent follow-up surveys occurred during May 2010, February
2011 and May-June 2011. Either the CDC bottle bioassay [38] or WHO paper-based bioassay
[39] were conducted to determine susceptibility of local Ae. aegypti populations to deltamethrin
at baseline (Nov. 2009), May 2010, July 2010, February 2011, April 2011, and August 2011. Eggs
were collected from clusters using ovitraps and were hatched and reared to adults (F0) for use
in bioassays. Entomological data was a secondary outcome of the trial. The number of adult
female Ae. aegypti per house had the greatest relevance to transmission risk [40, 41].
Data analysis
Data were exported from a custom Microsoft Access database and analyzed using SAS statisti-
cal analysis software version 9.3 and R version 3.4.3. The effect of the intervention was esti-
mated by calculating cluster-level summary measures and comparing them between arms by
unpaired t test. For seroconversion, a rate per person-year was calculated for each cluster.
Those at risk were those with a baseline PRNT measurement indicating they were not already
positive for all four DENV serotypes. The numerator for the rate was the number of people
who seroconverted to one or more serotypes between the surveys. The denominator was the
person-time between the first and second surveys of those at risk. For the entomological end-
points, the area under the curve was calculated for each cluster. The follow-up values of the
entomological endpoints were summarized in terms of the area under the curve (AUC) of the
index against time estimated by trapezium rule, taking each time point as the mean survey
date for each cluster [42, 43]. No subgroup or adjusted analyses were done.
Results
At baseline, the demographic composition was similar between participants in intervention
and control arms (Table 1).
Seroprevalence and seroconversion data from individuals that provided samples at baseline
and follow-up are presented in Table 2 (also see S1 Summary. In both the intervention and
control arms, approximately 90% of participants had antibodies to at least one DENV serotype
at baseline and approximately 85% of all participants were seronegative to at least one DENV
serotype. There was a significant difference in overall seroconversion rates (seroconversion to
any individual serotype or multiple serotypes; p<0.0001) between the intervention and control
arms. At baseline, the intervention arm had an average seroconversion rate of 50.6 per 100 per-
son-years (PY) (CI: 29.9–71.9) and those in the control arm had an average seroconversion
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rate of 37.4 per 100 PY (CI: 15.2–51.7). This represents a statistically significant mean differ-
ence of 13.2 (CI: 12.0–14.4), with higher incidence in the intervention arm, or a difference
equivalent to 35% of the average rate in the control arm.
For entomological endpoints, the adult female Aedes index and the Breteau Index are
shown in Figs 3 and 4, other indices are presented in supplementary material (S1 Summary).
Overall, entomological indices were similar across treatment and control arms over the course
of the study (Table 3). There were no significant differences detected between the intervention
and control arms for any of the adult or immature Ae. aegypti indices that were measured.
Cone bioassays after re-treatment with KO-Tab 123 showed that the curtains did not imme-
diately recover to the 100% bioefficacy observed at baseline. At 1 month following re-treat-
ment (January 2011) average mortality for 36 ITCs was 74.5% (range: 48%-94%). By 9-months
following re-treatment (August 2011) average mortality from 9 test curtains was 97.2% (range:
87.5%-100%).
Insecticide susceptibility data from CDC bottle bioassays demonstrated that the local Ae.
aegypti population was fully susceptible to deltamethrin at baseline and remained fully suscep-
tible when tested during May 2010 and July 2010. Resistance to deltamethrin was first detected
during February 2011, when 24-hour mortality using the WHO bioassay dropped to 79.7%
and was at a similar level (74.8%) during April 2011. Mortality fell further to 68.3% (using the
CDC bottle bioassay) during August 2011.
Discussion
The results indicate that participants living in the intervention arm were not better protected
from DENV exposure than those in the control arm, despite the widespread use of ITCs.
Although entomological indicators appeared to be lower in the intervention arm, most notably
at the first follow-up survey, the differences were not statistically significant and were not sus-
tained over the course of the study. These findings are in contrast with previous studies that
have demonstrated clear entomological impacts of ITCs in cluster-randomized trials [11, 13–
16]. While previous studies of ITCs reported serological endpoints [11, 16], no other CRT had
been powered based on seroconversion data. This trial was unique, therefore, because it
benefited from multiple years of data collection from previous studies of dengue epidemiology
in Iquitos. That stated, participants in the intervention arm were more likely to report reduced
use of other mosquito products due to the feeling of protection from the ITCs compared to
those in the control arm [17, 44].
Table 1. Baseline participant demographics.
Intervention Arm Control Arm
Number (%)
(n = 1721)
Number (%)
(n = 1656)
Gender
Male 739 (42.9%) 704 (42.5%)
Female 982 (57.1%) 952 (57.5%)
Age (years)
3–20 772 (44.9%) 783 (47.3%)
21–40 584 (33.9%) 493 (29.8%)
> = 41 365 (21.2%) 380 (23.0%)
Mean 27.1 26.6
https://doi.org/10.1371/journal.pntd.0008097.t001
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That the participants in the intervention arm were more likely to seroconvert to DENV
infection was surprising, especially given the high use of the ITCs [17, 44] and the promising
entomological data reported in previous trials. Three factors, however, could have contributed
to this unexpected result. First, despite being fabricated from a material that was expected to
retain high insecticide levels over the course of several years, the ITCs quickly lost insecticidal
efficacy, leading to the need for mass re-treatment only 1-year after they had been originally
Table 2. Seroprevalence at baseline and seroconversion in intervention (n = 918) and control (n = 1007) arms.
Cluster Participants with
baseline and follow-up
samples
(n)
Positive
seroprevalence at
baselinea
(n)
Participants at risk of
seroconversionb
(n)
Seroconversion to different serotypes during the study (Seroconversion
rate/100 person-years)c
DENV1
only
DENV2
only
DENV3
only
DENV4
only
Multiple
serotypesd
Any
serotypee,f
Intervention
arm
2 70 65 (92.9%) 66 (94.3%) 2.1 6.3 4.2 52.8 6.3 71.9
4 94 82 (87.2%) 89 (94.7%) 4.9 13.0 11.3 32.4 9.7 71.2
7 60 55 (91.7%) 55 (91.7%) 0.0 7.8 2.6 28.7 7.8 46.9
10 103 91 (88.3%) 91 (88.3%) 9.7 6.5 1.6 34.0 6.5 58.3
11 96 73 (76.0%) 73 (76.0%) 4.0 2.0 0.0 35.9 4.0 45.9
12 98 81 (82.7%) 81 (82.7%) 21.8 1.8 1.8 25.4 1.8 52.6
14 118 87 (73.7%) 87 (73.7%) 10.2 1.7 0.0 11.9 8.5 32.2
15 104 82 (78.8%) 82 (78.8%) 7.1 3.6 5.4 32.2 10.7 58.9
18 86 72 (83.7%) 72 (83.7%) 3.9 0.0 1.9 31.1 0.0 36.9
20 89 80 (89.9%) 80 (89.9%) 1.9 5.6 1.9 14.9 5.6 29.9
Mean 91.8 82.8 (90.2%) 77.6 (84.5%) 7.0 4.9 3.1 29.4 6.2 50.6f
Range (60–118) (55–108), (80.6%-
98.8%)
(55–91),
(73.7%-94.7%)
(0.0–
21.8)
(0.0–
13.0)
(0.0–
11.3)
(11.9–
53.8)
(0.0–10.7) (29.9–71.9)
Control arm
1 81 75 (92.6%) 65 (80.2%) 11.2 9.0 2.3 20.2 9.0 51.7
3 68 56 (82.4%) 58 (85.3%) 5.0 10.0 0.0 12.5 7.5 35.0
5 74 60 (81.1%) 69 (93.2%) 4.3 0.0 0.0 27.8 15.0 47.0
6 94 85 (90.4%) 80 (85.1%) 1.8 7.4 5.5 7.4 14.7 36.8
8 168 150 (89.3%) 143 (85.1%) 4.2 8.3 2.1 16.6 15.6 46.7
9 127 113 (89.0%) 119 (93.7%) 7.5 2.5 0.0 13.7 6.2 29.8
13 91 79 (86.8%) 74 (81.3%) 6.0 8.1 0.0 10.1 12.1 36.3
16 97 91 (93.8%) 82 (84.5%) 1.8 1.8 1.8 30.8 3.6 39.8
17 94 88 (93.6%) 75 (79.8%) 0.0 2.0 2.0 21.8 11.9 37.6
19 113 108 (95.6%) 88 (77.9%) 0.0 0.0 1.7 11.8 1.7 15.2
Mean 100.7 93.7 (89.4%) 85.3 (84.7%) 4.2 4.8 1.6 17.0 9.9 37.4f
Range (68–168) (58–160), (82.3%-
95.7%)
(58–143), (77.9%-
93.7%)
(0.0–
11.2)
(0.0–
10.0)
(0.0–5.5) (7.4–
30.8)
(1.7–15.6) (15.2–51.7)
aThe number of participants and total percentage of individuals with positive serological tests for 1 to 4 of the 4 DENV serotypes at baseline, among those with both
baseline and follow-up samples
bThe number of participants and total percentage of individuals at risk of seroconversion (i.e., without full immunity to all 4 DENV serotypes), among those with both
baseline and follow-up samples
cDENV1-DENV4: Seroconversion to one, and only one, of these serotype during the course of the study
dSeroconversion to more than one of the four DENV serotypes during the course of the study
eAny seroconversion, including any single serotype conversion (DENV1-DENV4), or conversion to multiple serotypes, that took place during the study
fAny serotype conversion significant difference from the control arm; t-value -21.45, mean difference 13.2, 95% CI (-14.4, -12.0), p-value <0.0001
https://doi.org/10.1371/journal.pntd.0008097.t002
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deployed. The 9-month serosurvey occurred before the ITCs were re-treated, which means
that many were operating sub-optimally and could have potentially had reduced protective
effectiveness. Second, a contributing factor may have been a false sense of security amongst the
participants in the intervention arm; i.e., perhaps the presence of the highly visible ITCs cre-
ated a belief in their protective power among the treated households, who subsequently did
not employ any additional measures typically used to avoid exposure to mosquito bites. This
possibility was suggested as an explanation for a similar outcome associated with the use of
insecticide aerosols and mosquito coils in a meta-analysis of dengue interventions [45].
Indeed, comments by participants about the expected benefit of the ITCs were noted during
focus group discussions held 6-months after the ITCs were deployed. Participants that had
Fig 3. The average number of female Ae. aegypti collected per house. Intervention clusters are shown in red and control clusters are shown in
blue. The upper and lower limits of each box are the interquartile range across clusters. Each ‘whisker’ (dashed line) extends to the most extreme data
point which is no more than 1.5 times the interquartile range from the box. Circles represent values which are more extreme than the whiskers. The
baseline data are represented by the boxes corresponding to October/November 2009.
https://doi.org/10.1371/journal.pntd.0008097.g003
Fig 4. The Breteau index, with results from intervention clusters shown in red and control clusters shown in blue. Boxes in the intervention period
are joined by lines. The upper and lower limits of each box are the interquartile range across clusters. Each ‘whisker’ (dashed line) extends to the most
extreme data point which is no more than 1.5 times the interquartile range from the box. Circles represent values which are more extreme than the
whiskers. The baseline data are represented by the boxes corresponding to October/November 2009.
https://doi.org/10.1371/journal.pntd.0008097.g004
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received ITCs commented that when the curtains were first hung, the household reduced their
use of mosquito repellents and stopped fumigating because they felt that it was no longer nec-
essary due to the presence of the ITCs [17]. Third, higher baseline seroconversion rates in
treatment than control clusters (Table 2) could reflect higher transmission risk for people in
treatment areas; i.e., treatment and control clusters were not balanced for transmission risk.
Other complicating factors that should be considered for interpretation of our results are
the close proximity of the study clusters, high mobility [46–49] of people in Iquitos, and study
duration. Treated clusters were located across the street from untreated clusters. There were a
few reports of family members in treated clusters loaning curtains to family members in an
untreated cluster. The study population did not spend 100% of their time at their homes under
protection of the ITCs. Theoretically, randomization would control for this, but a penalization
for human movement patterns in and out of clusters was not included in our original sample
size calculations or study design. After our RCT had been carried out, a series of publications
offered recommendations for how to enhance the design RCTs to assess the epidemiological
effects of interventions against Aedes-transmitted viruses [50–55]. The geographic spacing of
clusters and accounting for human movement will be critical for future RCT study designs
[53]. Of particular relevance to our study are insights that would minimize the complicating
effects of movement and ways to gather movement data that will support quantifying a per-
son’s time under coverage; e.g., see [53]. We measured seroconversions for only a single
9-month period (i.e., a single transmission season) and discontinued the study because of
higher transmission rates observed in the ITC treated areas, which was associated with a high
force of infection for DENV4 and unusually high entomological indices. A minimum of 2
transmission season is needed to account for interannual variation in virus transmission and
vector population dynamics.
Results related to analyses of behaviors associated with ITC use provided the first indication
that the ITCs were not functioning as expected. During focus group discussions conducted 6
months after the ITCs were hung, a common theme that emerged was the perception that the
ITCs were working initially, but that their insecticidal impact seemed to wane rapidly. These
observations were corroborated with quantitative data collected during a knowledge, attitudes,
and practices (KAP) survey, which was conducted 9-months after ITCs were deployed. A third
of the KAP survey respondents reported that they observed a temporary drop in the amount of
mosquitoes in their homes. Overall, the surveyed population perceived that mosquito numbers
were only lowered for an average of 3.3 months after the ITCs were hung [17].
Table 3. Summary of AUC analyses of entomological endpoints between intervention and control arms.
Area under the curve (AUC):
mean (SD) over clusters, based
on time in days
Difference in AUC, intervention minus control (95% confidence interval) p-
value1
Intervention arm Control arm
Adult female Aedes aegypti per house 258 (134) 276 (135) -17 (-144, 109) 0.77
Adult Aedes aegypti per house (males and
females)
467 (230) 507 (219) -42 (-253, 169) 0.68
Breteau Index 5444 (2343) 6286 (3014) -841 (-3389, 1706) 0.50
Pupae per person 62.4 (32.5) 56.2 (35.1) 6.19 (-25.6, 38.0) 0.69
House Index 4112 (1500) 4868 (1721) -756 (-2275, 764) 0.31
Container Index 1793 (842) 2123 (917) -330 (-1157, 497) 0.41
1t test. Negative values favor the intervention.
https://doi.org/10.1371/journal.pntd.0008097.t003
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Bioassays detected an increase in resistance to deltamethrin in the local Ae. aegypti popula-
tion over the course of the study. Resistance was first detected in early 2011, after ITCs had
been deployed for over a year, soon after they were re-treated with deltamethrin. This initial
detection of resistance was worrying, because it could indicate that low concentrations of
insecticide on ITCs that were not adequately loaded with deltamethrin (the reason why the re-
treatment was carried out) had already begun to select for deltamethrin resistance in the local
mosquito population.
While the outcomes of our study were unanticipated, they highlight several key challenges
related to the widespread community use of ITCs to reduce dengue transmission. First, key
dynamics influencing the potential of this tool in Iquitos appeared to have been dependent on
human behavior in ways other than those we had considered. For example, while the commu-
nity readily adopted and used the ITCs [44], they may have done so at the expense of other
protective measures. Hence households using ITCs that were later confirmed to be faulty, were
at greater risk of seroconverting to dengue. Future ITC-based interventions will need to take
great care in emphasizing that ITCs should supplement, rather than replace, existing protective
strategies. Second, the quality of the insecticide-treated material is fundamental to the success
of the intervention. Failures in efficacy can lead to difficulty in interpreting results from a trial.
The reduced insecticidal effect of the ITCs was associated with the initial detection of deltame-
thrin resistance in the local Ae. aegypti population. This is particularly troubling in the case
of Ae. aegypti because arbovirus control programs are heavily reliant on a limited number of
approved insecticides. All insecticide-based interventions should include rigorous quality con-
trol during mass production of the finished trial product, to minimize the possibility that sub-
lethal doses of insecticide are deployed in target localities, which can lead to multiple negative
consequences.
Since this trial was completed a growing body of evidence indicates that the potential for
ITCs as vector control tools for reducing DENV transmission likely depends more on how
effectively they act as physical barriers to prevent mosquito ingress, than on how well they
deliver and sustain insecticidal efficacy. ITCs tightly fitted as screens to windows (and doors)
reduced indoor mosquito densities for long periods, even when they were untreated or after
the insecticide treatment had been lost [56, 57]. Although this is good news from the perspec-
tive of insecticide resistance, screening windows and doors will not be possible at every loca-
tion. Where communities live in houses with numerous openings to maximize air movement
(e.g. high eaves, floor to ceiling doorways, etc.), as in Iquitos, Thailand [43] and numerous
other locations, such screening would be impossible without major changes in home construc-
tion. Identifying effective means of protecting those communities against dengue and the
other infections transmitted by Ae. aegypti remains an obstinate challenge that will require
integration of multiple strategies, including approaches that are intersectoral and go beyond
traditional methods for vector control [58].
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